Skip Navigation
Skip to contents



10 results

Staphylococcal Endocarditis Presenting with a Renal Infarct in a Patient with Acute Lymphoblastic Leukemia

Son MH, Park ES, Seo JH, Lim JY, Park CH, Woo HO, Youn HS

  • Cancer Res Treat.
  • 2008 Sep;40(3):151-154.
We present here a patient with acute lymphoblastic leukemia (ALL) and who developed infective endocarditis during induction chemotherapy with prednisolone, L-asparaginase (Leunase(R)), vincristine and adriamycin. The patient did not have...
Primary Gastric Choriocarcinoma: Two Case Reports and Review of the Literatures

Yoon JH, Kim MS, Kook EH, Ahn SH, Jeong SY, Han MS, Huh JK, Kang HJ, Na II, Cho SY, Kim SB, Ryoo BY, Yang SH

  • Cancer Res Treat.
  • 2008 Sep;40(3):145-150.
Primary gastric choriocarcinoma (PGC) is a rare tumor, and its pathogenesis is still uncertain. Most PGCs have been reported to possess an adenocarcinoma component of variable extent, and pure PGC...
Hepatocellular Carcinoma Presenting as Uterine Metastasis

Kang WD, Kim CH, Cho MK, Kim JW, Lee JS, Kim YH, Choi HS, Kim SM

  • Cancer Res Treat.
  • 2008 Sep;40(3):141-144.
Metastatic extragenital cancer that spreads to the uterus is rare. When it occurs, the extragenital primary disease is often in the breast or gastrointestinal tract. We report here on a...
Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer

Ko YH, Jung CK, Lee MA, Byun JH, Kang JH, Lee KY, Jo KH, Wang YP, Hong YS

  • Cancer Res Treat.
  • 2008 Sep;40(3):133-140.
PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis...
The Bone Morphogenesis Protein-2 (BMP-2) is Associated with Progression to Metastatic Disease in Gastric Cancer

Park Y, Kim JW, Kim DS, Kim EB, Park SJ, Park JY, Choi WS, Song JG, Seo HY, Oh SC, Kim BS, Park JJ, Kim YH, Kim JS

  • Cancer Res Treat.
  • 2008 Sep;40(3):127-132.
PURPOSE: Bone Morphogenetic Proteins (BMPs) are members of the TGF-beta superfamily and it has been demonstrated that BMPs enhance migration, invasion and metastasis. The purpose of this study was to...
Clinical Correlation between Brain Natriutetic Peptide and Anthracyclin-induced Cardiac Toxicity

Lee HS, Son CB, Shin SH, Kim YS

  • Cancer Res Treat.
  • 2008 Sep;40(3):121-126.
PURPOSE: Anthracycline can effectively treat hematologic malignancies, but has significant risk of cardiotoxicity. We measured the clinical correlation between brain natriuretic peptide (BNP) and anthracycline-induced cardiotoxicity. MATERIALS AND METHODS: Between March...
Gemcitabine and Carboplatin Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Feasibility Study

Yuh YJ, Lee HR, Kim SR

  • Cancer Res Treat.
  • 2008 Sep;40(3):116-120.
PURPOSE: Although platinum based chemotherapy is known to improve the survival duration for the patients with non-small cell lung cancer, the role of platinum for elderly patient is not yet...
Initial Response to Treatment was Highly Associated with the Prognosis of Childhood Rhabdomyosarcoma: A Retrospective Analysis of a Single Center Experience in Korea

Park JA, Kim EK, Kang HJ, Shin HY, Kim IH, Ahn HS

  • Cancer Res Treat.
  • 2008 Sep;40(3):111-115.
PURPOSE: Following the introduction of a multimodal approach to diagnosis and treatment, the prognosis of rhabdomyosarcoma (RMS) has markedly improved over the last three decades. However, there are few data...
A Phase II Trial of Paclitaxel, 5-fluorouracil (5-FU) and Cisplatin in Patients with Metastatic or Recurrent Gastric Cancer

Kang GH, Kim GS, Lee HR, Yuh YJ, Kim SR

  • Cancer Res Treat.
  • 2008 Sep;40(3):106-110.
PURPOSE: We wanted to assess the effectiveness and safety of combination chemotherapy with paclitaxel, 5-fluorouracil (5-FU) and cisplatin for treating advanced gastric cancer. MATERIALS AND METHODS: Patients with metastatic or recurrent...
Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

Kim JH, Oh SY, Kwon HC, Lee S, Kim SH, Kim DC, Lee JH, Lee HS, Cho SH, Kim HJ

  • Cancer Res Treat.
  • 2008 Sep;40(3):101-105.
PURPOSE: Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: